Preclinical investigation of combined gene-mediated cytotoxic immunotherapy and immune checkpoint blockade in glioblastoma

BACKGROUND: Combined immunotherapy approaches are promising cancer treatments. We evaluated anti–programmed cell death protein 1 (PD-1) treatment combined with gene-mediated cytotoxic immunotherapy (GMCI) performed by intratumoral injection of a prodrug metabolizing nonreplicating adenovirus (AdV-tk...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Speranza, Maria-Carmela, Passaro, Carmela, Ricklefs, Franz, Kasai, Kazue, Klein, Sarah R, Nakashima, Hiroshi, Kaufmann, Johanna K, Ahmed, Abdul-Kareem, Nowicki, Michal O, Obi, Prisca, Bronisz, Agnieszka, Aguilar-Cordova, Estuardo, Aguilar, Laura K, Guzik, Brian W, Breakefield, Xandra, Weissleder, Ralph, Freeman, Gordon J, Reardon, David A, Wen, Patrick Y, Chiocca, E Antonio, Lawler, Sean E
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Basic and Translational Investigations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777502/
https://ncbi.nlm.nih.gov/pubmed/29016938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox139
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires